Latest News and Press Releases
Want to stay updated on the latest news?
-
SHANGHAI, CHINA, July 15, 2025 (GLOBE NEWSWIRE) -- Able View Global Inc. – (NASDAQ-CM: ABLV) (“Able View” or the “Company”) one of the largest comprehensive brand management partners of...
-
BYDFi MoonX launches a global KOL Recruitment program to expand its MemeCoin trading ecosystem and drive the future of on-chain trading.
-
Crypto Costa, BYDFi global ambassador, opens a short on XRP amid its rally — a bold contrarian move on the platform he represents.
-
FRAMINGHAM, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Definitive Healthcare (Nasdaq: DH), a leader in healthcare commercial intelligence, today announced the launch of Monocl Conferences. This...
-
JOYAJOY, the World’s 1st GAMIFIED Social Media, cultivates a Joyful Place for Influencers and Followers to share joy without worrying about cyberbullying.
-
Cash Labs partners with Nick Laws to launch Catalyst, a new talent division empowering digital innovators with a human-first approach to talent management.
-
LONDON and NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...
-
Chemomab's KOL primary sclerosing cholangitis virtual event on April 10 at 10:00 AM ET will include physician & patient PSC experts & a live Q&A session.
-
OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Multiple Signs and Symptoms of Dry Eye Disease including Ocular Pain Relief
-
-Phase 2 OK-101 efficacy data to be released March 22nd, 2024- -KOL Event to be held on April 9th, 2024 at 12 PM ET- LONDON and NEW YORK, March 21, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited...